tradingkey.logo
tradingkey.logo
Search

Icecure Medical Ltd

ICCM
Add to Watchlist
3.080USD
0.0000.00%
Close 08-07 16:00ETQuotes delayed by 15 min
225.22MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Haixiang (Li)
37.97%
Shamir (Eyal)
1.06%
Tsimerman (Ronen)
0.55%
Mayron (Ron)
0.54%
Tel-Tzure (Tlalit Bussi)
0.31%
Other
59.57%
Shareholders
Shareholders
Proportion
Haixiang (Li)
37.97%
Shamir (Eyal)
1.06%
Tsimerman (Ronen)
0.55%
Mayron (Ron)
0.54%
Tel-Tzure (Tlalit Bussi)
0.31%
Other
59.57%
Shareholder Types
Shareholders
Proportion
Individual Investor
41.43%
Investment Advisor
0.34%
Research Firm
0.24%
Hedge Fund
0.11%
Investment Advisor/Hedge Fund
0.05%
Bank and Trust
0.05%
Other
57.80%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
32
628.53K
0.77%
+106.96K
2025Q4
31
443.26K
0.64%
+86.28K
2025Q3
33
241.02K
0.35%
-53.58K
2025Q2
45
28.04M
40.84%
+56.20K
2025Q1
44
28.01M
47.78%
-9.18K
2024Q4
41
27.61M
48.82%
+489.62K
2024Q3
42
27.95M
49.54%
-2.17M
2024Q2
41
27.48M
56.81%
+3.00M
2024Q1
39
27.22M
56.29%
+2.63M
2023Q4
40
21.73M
47.63%
-6.82M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Haixiang (Li)
35.85M
44.16%
+10.00M
+38.69%
Mar 17, 2026
Shamir (Eyal)
590.31K
0.73%
+69.67K
+13.38%
Mar 24, 2025
Tsimerman (Ronen)
355.08K
0.44%
+47.55K
+15.46%
Mar 24, 2025
Mayron (Ron)
278.02K
0.34%
+55.45K
+24.91%
Mar 24, 2025
Tel-Tzure (Tlalit Bussi)
191.81K
0.24%
+35.32K
+22.57%
Mar 24, 2025
Levav (Shay)
141.86K
0.17%
+37.69K
+36.18%
Mar 24, 2025
Muchnik (Naum)
140.42K
0.17%
+35.13K
+33.36%
Mar 24, 2025
Huang (Yang)
113.44K
0.14%
+40.12K
+54.72%
Mar 24, 2025
Dotan (Merav Nir)
88.94K
0.11%
+30.84K
+53.09%
Mar 24, 2025
UBS Financial Services, Inc.
75.95K
0.09%
+60.34K
+386.48%
Dec 31, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.